Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug-discovery and development challenges. 

With around 700 highly educated scientists in six locations in Europe and two the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.  

Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf. 

Making Molecules Matter. Together.


Life Sciences

Pharmaceutical

Research

Symeres

Eelco Ebbers

Russell Thomas

Rory Curtis

Chris Teleha

Bart Decorte

Rutger Folmer

Dan Biesma

Guillaume Jetten

Katrien Swennen

Don Friederichs

Martin Caine Msc

Titia Mulders

Luc van Hijfte

The Research and Development team at Symeres specializes in advancing drug discovery and development by leveraging their extensive expertise in chemistry and medicinal chemistry. This team collaborates closely to design, synthesize, and analyze small to medium-sized molecules, guiding them through the early stages of development to the production of early clinical drug substance APIs. Their efforts are crucial in transforming scientific insights into tangible pharmaceutical solutions, ensuring that molecules matter.

Research and Development

Business Development Team

Leadership Team

Research and Development

About

Team members

Other teams at Symeres

Business Development Team

Leadership Team